Michelle Kreidt
Physician Assistant · Santa Ana, CANPI 1740840487
Payments from drug & device makers
Across 544 payments — averaging $23.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Lilly USA, LLC$1K
- Novo Nordisk$1K
- Boehringer Ingelheim$1K
- Amgen$946
- Biohaven Pharmaceuticals, Inc.$838
- plus $5K from 29 others
What the payments were for
- Consulting fees$8006%
- Food & beverage$11,76393%
- Education$951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 98 | $2,284 |
| Lilly USA, LLC | 52 | $1,214 |
| Novo Nordisk | 56 | $1,041 |
| Boehringer Ingelheim | 45 | $1,012 |
| Amgen(2 entities) | 42 | $946 |
| Biohaven Pharmaceuticals, Inc. | 3 | $838 |
| Bayer | 20 | $610 |
| AbbVie | 26 | $557 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $404 |
| GSK | 20 | $389 |
| Novartis | 18 | $389 |
| Pfizer | 14 | $298 |
| Amarin Pharma, Inc. | 21 | $290 |
| Sanofi-aventis U.S. LLC | 17 | $252 |
| Mannkind Corporation | 13 | $243 |
| Corcept Therapeutics | 8 | $211 |
| Xeris Pharmaceuticals, Inc. | 9 | $201 |
| Dexcom, Inc. | 9 | $192 |
| Astellas Pharma US Inc | 7 | $191 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $178 |
| Exact Sciences | 6 | $123 |
| Kowa Pharmaceuticals America, Inc. | 6 | $120 |
| Merck | 5 | $115 |
| Radius Health, Inc. | 4 | $103 |
| Abbott | 4 | $98 |
| Insulet Corporation | 3 | $87 |
| Johnson & Johnson | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 3 | $40 |
| Cequr Corporation | 2 | $27 |
| Medtronic | 2 | $24 |
| Echosens North America, Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Biogen | 1 | $17 |
| Endogastric Solutions, Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
- CUVITRU$240
- Kerendia$120
How this compares
$12,658 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 61 | $72,467 |
| RybelsusSemaglutide | 27 | $55,324 |
| OzempicSemaglutide | 39 | $52,170 |
| FarxigaDapagliflozin Propanediol | 31 | $41,108 |
| MounjaroTirzepatide | 28 | $29,347 |
| JanuviaSitagliptin Phosphate | 30 | $21,480 |
| JardianceEmpagliflozin | 21 | $20,484 |
| EliquisApixaban | 12 | $15,870 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 14 | $13,923 |
| VascepaIcosapent Ethyl | 31 | $13,783 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $11,845 |
| XareltoRivaroxaban | 15 | $7,904 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $3,600 |
| Comfort Ez Pen NeedlePen Needle, Diabetic | 32 | $2,804 |
| Rivastigmine | 28 | $2,444 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $1,041 | $107,49466 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $1,214 | $101,81489 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $2,284 | $52,95348 claims |
| MerckJanuvia | $115 | $21,48030 claims |
| Boehringer IngelheimJardiance | $1,012 | $20,48421 claims |
| PfizerEliquis | $298 | $15,87012 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $252 | $13,92314 claims |
| Johnson & JohnsonXarelto | $66 | $7,90415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Santa Ana
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.